South Korea Insulin Infusion Pump Market Size, Share, and COVID-19 Impact Analysis, By Type (Traditional Insulin Pumps, Patch Pumps), By End-User (Hospitals, Homecare, Ambulatory Care Centers), and South Korea Insulin Infusion Pump Market Insights, Industry Trend, Forecasts to 2035

South Korea Insulin Infusion Pump Market Insights Forecasts to 2035

• The South Korea Insulin Infusion Pump Market Size was Estimated at USD 72.6 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 3.85% from 2025 to 2035
• The South Korea Insulin Infusion Pump Market Size is Expected to Reach USD 110.0 Million by 2035

According to a research report published by Spherical Insights and Consulting, The South Korea Insulin Infusion Pump Market Size is anticipated to reach USD 110.0 Million by 2035, growing at a CAGR of 3.85% from 2025 to 2035. Some of the major factors propelling the market include the country's rising diabetes prevalence, the implementation of various government initiatives, the speed at which technology is developing, and the incorporation of artificial intelligence (AI) and the Internet of Things (IoT) in pumps.

Market Overview

The industry that includes medical devices intended to continuously administer subcutaneous insulin to diabetics is known as the South Korea Insulin Infusion Pump Market. These gadgets, also referred to as insulin pumps, offer more accurate and flexible insulin delivery as an alternative to several daily insulin injections. Additionally, the use of these devices is increasing due to advancements in insulin pump technology. The Korean Health Industry Development Institute (KHIDI) claims that insulin pumps with functions like automated insulin delivery and integration with continuous glucose monitoring (CGM) enhance treatment results. The demand for insulin infusion pumps is rising nationwide as a result of these technological advancements, which have improved patient satisfaction and disease management. Moreover, expanding access to insulin infusion pumps, especially for those with severe diabetes, has been made possible in large part by the South Korean government. The Ministry of Health and Welfare (MOHW) claims that for eligible patients, insulin pumps are covered by the national health insurance program, which reduces costs and promotes the use of contemporary diabetes care equipment. Because of this legislative support, the industry is growing and more patients will have access to insulin infusion pumps.

Report Coverage

This research report categorizes the market for the South Korea insulin infusion pump market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea insulin infusion pump market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the South Korea insulin infusion pump market.

Driving Factors

The key factors driving the market's expansion is South Korea's rising diabetes prevalence, which has increased demand for effective and cutting-edge insulin delivery devices like insulin infusion pumps. In addition, the growing use of the product is driving market expansion since it provides a more precise and practical way to control blood sugar levels than conventional techniques. Additionally, a favorable environment for the market's expansion is being created by the execution of numerous government programs that promote research and development (R&D) and increased investments in medical devices. The market is expected to grow as a consequence of the quick technical developments that are improving the functionality and efficiency of insulin infusion pumps. Such type of these developments includes the addition of features like real-time glucose monitoring, synchronization of mobile applications, and predictive algorithms.

Restraining Factors

Insulin infusion pumps are costly to buy initially and maintain over time. Access to these devices is restricted by their high cost, especially for patients with inadequate insurance coverage. A major obstacle to widespread adoption, particularly for those from lower-income backgrounds, is affordability, even with technological advancements.

Market Segmentation

The South Korea Insulin Infusion Pump Market share is classified into type and end-user.

• The traditional insulin pump segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea insulin infusion pump market is segmented by type into traditional insulin pumps and patch pumps. Among these, the traditional insulin pump segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Diabetic patients can maintain better glucose control with the more accurate control that traditional insulin pumps provide over insulin delivery. These pumps mimic the action of a healthy pancreas by continuously delivering insulin, lowering the risk of complications like hypoglycemia or hyperglycemia. Demand is fueled by this degree of accuracy and ease, particularly from patients who find traditional injection techniques difficult.

• The hospitals segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea insulin infusion pump market is segmented by end user into hospitals, homecare, and ambulatory care centers. Among these, the hospitals segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Driven by the large number of diabetic patients in need of ongoing insulin treatment and sophisticated monitoring. Hospitals benefit from specialized healthcare infrastructure that guarantees accurate patient management and insulin delivery.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea insulin infusion pump market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Modtronic Korea
• Roche Diabetes Care Korea
• Insulet Corporation
• Ypsomed Korea
• Valeritas.Inc
• Others

Recent Developments:

• In January 2024, Medtronic launched the MiniMed™ 780G insulin infusion pump in South Korea, featuring advanced SmartGuard™ technology for automated insulin delivery and improved glucose management.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea Insulin Infusion Pump Market based on the below-mentioned segments:

South Korea Insulin Infusion Pump Market, By Type

• Traditional Insulin Pumps
• Patch Pumps

South Korea Insulin Infusion Pump Market, By End-user

• Hospitals
• Homecare
• Ambulatory Care Centers